Abstract
Therapeutic radiologists have sought means of improving radiation effects on tumors relative to normal tissues for over 50 years. Regaud (1922) demonstrated that the same biological end result could be achieved with a single large, or multiple small increments of radiation, and that the multiple smaller doses caused far less injury to normal tissues. Coutard (1926) described favorable results of the clinical application of Regaud’s work leading to the fractionated-dose radiotherapy techniques in use today. This discovery, along with dramatic advances in the physics and technology of radiation therapy and accumulated knowledge and experience in the application of this technology, have led to marked improvement in survival rates of patients with most forms of cancer. Although radiobiologists and radiation therapists have not made breakthroughs as significant as that of Regaud and Coutard, clinical investigation of methods to increase radiation response is proceeding in three major areas: (1) physiologic (i.e. increasing oxygen concentration in tumors), (2) physical (i.e. using heavy particle, high linear energy transfer radiations), and (3) chemical. The purpose of this section is to discuss the third method.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andrews, J.R.: Combined cancer radiotherapy and chemotherapy: the relevance of cell population kinetics and pharmacodynamics. Cancer Chemother. Rep. 53, 313–324 (1969).
Aur, J.A., Simone, J. V., Hustu, H.O., Verzosa, M.S.: A comparative study of central nervous system irradiation and intensive chemotherapy early in remission of childhood acute lymphocytic leukemia. Cancer 29, 381–391 (1972).
Bagshaw, M.A.: Modification of the radiosensitivity of hamster cells in vitro. Nature (Lond.) 193, 389–391 (1962).
Bagshaw, M.A., Doggett, R.L.S.: A clinical study of chemical radiosensitization. Frontiers of Radiation Therapy and Oncology, Vol.4. Basel, New York: Karger. San Francisco: Vaeth 1969.
Bagshaw, M.A., Doggett, R.L.S., Smith, K.C., Kaplan, H.S., Nelsen, T.S.: Intra-arterial 5-bromodeoxyuridine and x-ray therapy. Amer. J. Roentgenol. 99, 886–894 (1967).
Bases, R.: Modification of radiation response by single-cell technics: Actinomycin D. Cancer Res. 19, 1223–1233 (1959).
Belli, J. A.: Proliferation kinetics of normal and tumor cells. Radiology 105, 143–149 (1972).
Berry, R. J.: Modification of radiation effects. Radiol. Clin. N. Amer. 3, 249–264 (1965).
Berry, R.J.: Growing points in mammalian radiobiology and their implications for radiotherapy. Radiol. Clin. N. Amer. 2, 281–292 (1969).
Berry, R. J., Hall, E. J., Cavanagh, J.: Radiosensitivity and the oxygen effect for mammalian cells cultured in vitro in stationary phase. Brit. J. Radiol. 43, 81–90 (1970).
Bruce, W.R., Meeker, B.E., Valeriote, F.A.: Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo. J. nat. Cancer Inst. 37, 233–245 (1966).
Brookes, P., Lawley, P.D.: The alkylation of guanosine and guanylic acid. J. chem. Soc. 3923–3932 (1961).
Brown, J.M.: The effect of acute X-irradiation on the cell proliferation kinetics of induced carcinomas and their normal counterpart. Radiat. Res. 43, 627–653 (1970 a).
Brown, J.M., Berry, R.J.: Effect of X-irradiation on the cell population kinetics in a model tumor and normal tissue system: implications for the treatment of human malignancies. Brit. J. Radiol. 42, 372–377 (1969).
Brown, J.M., Goffinet, D.R.: A technique for intra-arterial infusion of tumor bearing mice. J. Lab. clin. Med. 76, 175–180 (1970b).
Brown, J.M., Goffinet, D.R., Cleaver, J.E., Kallman, R.F.: Preferential radiosensitization of mouse sarcoma relative to normal skin by chronic intraarterial infusion of halogenated pyrimidine analogues. J. nat. Cancer Inst. 47, 75–89 (1971).
Capizzi, R.L., DeConti, R.C., Maesh, J.C., Bertino, J.R.: Methotrexate therapy of head and neck cancer: improvement in therapeutic index by the use of leucovorin “rescue.” Cancer Res. 30, 1782–1788 (1970).
Cassady, J.R.: Considerations in radiation therapy of Wilms’ tumor. Cancer 32, 598–608 (1973).
Cassady, J.R., Sagerman, R.H., Tretter, P., Ellsworth, R.M.: Radiation therapy in retinoblastoma. Radiology 93, 405–409 (1969).
Catterall, M., Rogers, C.: An investigation into the clinical effects of fast neutrons. Brit. J. Radiol. 44, 603–611 (1971).
Chalmers, T.C.: Combination of radiotherapy and chemotherapy in the treatment of carcinoma of the lung. Cancer Chemother. Rep. 16, 463–471 (1962).
Clapp, P., Tayao, M.S., Tyree, E.B., Nickson, J. J., Clarkson, B., Lawrence, W., Jr.: An experimental study of simultaneous irradiation and regional chemotherapeutic perfusion. J. surg. Res. 4, 371–376 (1964).
Cohen, J.L., Krant, M.J., Shnider, B.L., Matias, P.L., Horton, J., Baxter, D.: Radiation plus 5-fluorouracil (NCS-19893): clinical demonstration of an additive effect in broncho-genie carcinoma. Cancer Chemother. Rep. 55, 253–258 (1971).
Condit, P.T.: Treatment of carcinoma with radiation therapy and methotrexate. Missouri Med. 65, 823–835 (1968).
Correa, J.N., Andrews, J.R.: Modification of radiation effect of ascitic tumor cells by pharmacologic agents injected intravenously. Nature (Lond.) 203, 200–208 (1964).
Coutard, H.: Roentgen therapy of epitheliomas of the tonsillar region, hypopharynx and larynx from 1920 to 1926. Amer. J. Roentgenol. 28, 313–331 (1932).
Daly, J.F., Friedman, M.: Combination irradiation and chemotherapy in the treatment of squamous cell carcinoma of the head and neck. Trans. Amer. Acad. Opthal. 68, 625–643 (1964).
D’Angio, G.J., Färber, S., Maddock, C.L.: Potentiation of x-ray effects by Actinomycin D. Radiology 73, 175–182 (1959).
Devita, V.T.: Cell kinetics and the chemotherapy of cancer. Cancer Chemother. Rep. 2, 23–33 (1971).
Devita, V.T., Serpick, A.: Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Proc. Amer. Assoc. Cancer Res. 8, 13 (1967).
Dewey, W.C., Humphrey, R.M.: Increase in radiosensitivity of ionizing radiation related to replacement of thymidine in mammalian cells with 5-bromodeoxyuridine. Radiat. Res. 26, 538–547 (1965).
Djerassi, L., Rominger, C. J., Kim, J.S., Turchi, J., Suvansri, U., Hughes, D.: Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer. Cancer 30, 22–30 (1972).
Djordjevic, B.: Sensitization by BUdR and repair of radiation damage in synchronized cells. Livre. Des. Resumes, 4th International Congress of Radiat. Research (1970).
Doggett, R.L.S., Bagshaw, M.A., Kaplan, H.S.: Combined therapy using chemotherapeutic agents and radiotherapy. Modern trends in radiotherapy, Vol. 1. London: Butterworths 1967.
Donaldson, S.S., Castro, J.R., Wdlbur, J.R., Jesse, R.H., Jr.: Rhabdomyosarcoma of head and neck in children: combination treatment by surgery, irradiation and chemotherapy. Cancer 31, 26–35 (1973).
Edland, R.S., Javid, M., Ansfield, F. J.: Glioblastoma multiforme: an analysis of the results of postoperative radiation therapy alone vs. radiotherapy and concomitant 5-fluorouracil; a prospective randomized study of 32 cases. Amer. J. Roentgenol. 111, 337–342 (1971).
Edland, R.S., Wear, J.B., Jr., Ansfield, F. J.: Advanced cancer of the urinary bladder: an analysis of the results of radiotherapy alone vs. radiotherapy and concomitant 5-fluorouracil; a prospective randomized study of 36 cases. Amer. J. Roentgenol, 108, 124–129 (1970).
Elkind, M.M., Sakamoto, K.: Combined effects of X-irradiation and chemotherapeutic drugs (nitrogen mustard and actinomycin D). Frontiers of Radiation Therapy and Oncology, Vol. 4. Basel-New York: Karger; San Francisco: Vaeth 1969.
Elkind, M.M., Kano, E.: Radiation-induced age-response changes in Chinese-hamster cells: evidence for a new form of damage and its repair. Int. J. Radiat. Biol. 19, 547–560 (1971).
Elkind, M.M., Whitmore, G.F.: Radiobiology of cultured mammalian cells. New York: Gordon and Greech 1967.
Erikson, R.L., Szybalski, W.: Molecular radiobiology of human cell lines. I. Comparative sensitivity to X-ray and ultraviolet light of cells containing halogen substituted DNA. Biochem. biophys. Res. Comm. 4, 258–267 (1961).
Erikson, R.L., Szybalski, W.: Molecular radiobiology of human cell lines. III. Radiation sensitizing properties of 5-iododeoxyuridine. Cancer Res. 23, 122–131 (1963 a).
Erikson, R.L., Szybalski, W.: Molecular radiobiology of human cell lines. V. Comparative radiosensitizing properties of 5-halodeoxycytidines and 5-halodeoxyuridines. Radiat. Res. 20, 252–261 (1963b).
Farber, S., D’Angio, G., Evans, A., Mrrus, A.: Clinical studies of actinomycin D with special reference to Wilms’ tumor in children. Ann. N. Y. Acad. Sci. 89, 421–440 (1960).
Fletcher, G.H., Suit, H.D., Howe, C.D., Samuels, M., Jesse, R.H., Jr., Villareal, R.U.: Clinical method of testing radiation-sensitizing agents in squamous cell carcinoma. Cancer 16, 355–363 (1963).
Frei, E., Shirakawa, S., Luce, J.K., Tannock, L.: Cell proliferation in human melanoma. J. Clin. Invest. 49, 1188–1199 (1970).
Frenkel, E.P., Arthur, C.: Induced ribotide reductive conversion defect by hydroxyurea and its relationship to megaloblastosis. Cancer Res. 27, 1016–1019 (1967).
Friedman, M., Denarvaes, F.N., Daly, J.F.: Treatment of squamous cell carcinoma of the head and neck with combined methotrexate and irradiation. Cancer 26, 711–721 (1970).
Fuks, Z., Smith, K.C.: Effects of quinacrine on x-ray sensitivity and the repair of damaged DNA in E. coli K-12. Radiat. Res. 48, 63–73 (1971).
Goffinet, D.R., Brown, J.M., Bagshaw, M.A., Kaplan, H.S.: Prolonged carotid arterial radiosensitizer infusion and radiation therapy of mouse gliomas. Amer. J.Roentgenol. 114, 7–15 (1972).
Goldberg, I.H., Rabinowitz, M.: Actinomycin D inhibition of deoxyribonucleic aciddependent synthesis of ribonucleic acid. Science 136, 315–331 (1962).
Gollin, F.F., Ansfield, F.J., Brandenburg, H.H., Vermund, H.: Combined therapy in advanced head and neck cancer: a ramdozied study. Amer. J. Roentgenol. 114, 83–88 (1972).
Gollin, F.F., Johnson, R.O.: Pre-irradiation 5-fluorouracil infusion in advanced head and neck carcinomas. Cancer 27, 768–770 (1971).
Greer, S., Zamenhof, S.: Effect of 5-bromouracil in deoxyribonucleic acid of E. coli on sensitivity to ultraviolet radiation. Abstr. Amer. ehem. Soc, 131st Meeting, p. 3 c (1957).
Hahn, G.M.: Radiochemotherapy of cell cultures containing cycling and non-cycling cells. Frontiers of Radiation Therapy and Oncology, Vol. 4. Basel-New York: Karger; San Francisco: Vaeth 1969.
Hahn, G.M., Steward, J.R., Yang, S. J., Parker, V.: Chinese hamster cell monolayer cultures. I. Changes in cell dynamics and modification of the cell cycle with period of growth. Exp. Cell Res. 49, 285–292 (1968a).
Hahn, G., Yang, S.J., Parker, V.: Repair of sublethal damage and unscheduled DNA synthesis in mammalian cells treated with monofunctional alkylating agents. Nature (Lond.) 220, 1142–1151 (1968b).
Heidelberger, C., Chaudhttri, N.K., Danneberg, P., Mooren, D., Greisbach, L., Duschinsky, R., Schnitzer, R. J., Pleven, E., Scheiner, J.: Fluorinated pyrimidines. A new class of tumor-inhibitory compounds. Nature (Lond.) 179, 663–677 (1957).
Heidelberger, C., Greisbach, L., Montag, B. J., Mooren, D., Cruz, O.: Studies of fluorinated pyrimidines. II. Effects on transplanted tumors. Cancer Res. 18, 305–314 (1958).
Hertz, R.J., Lewis, J., Lippsett, M.B.: Five years’ experience with chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in women. Amer. J. Obstet. Gynec. 82, 631–643 (1961).
Hoshino, T., Barker, N.S., Wilson, C.V., Bolderk, E.W., Fewer, D.: Cell kinetics of human gliomas. J. Neurosurg. 37, 15–26 (1972).
Hoshino, T., Sano, K.: Radiosensitization of malignant brain tumors with bromouridine (thymidine analogue). Acta radiol. 8, 98–113 (1969).
Hreshchyshyn, M.M.: Hydroxyurea (NSC-32065) with irradiation for cervical carcinoma-preliminary report. Cancer Chemother. Rep. 52, 601–602 (1968).
Jesse, R.H.: Combined intra-arterial infusion and radiotherapy for treatment of advanced cancer of the head and neck. Frontiers of Radiation Therapy and Oncology, Vol. 4. Basel-New York: Karger; San Francisco: Vaeth 1969.
Johnson, H.A., Haymaker, W.E., Rubini, J.R., Fliedner, T.M., Bond, V.P., Cronktte, E.P., Hughes, W.L.: A radiographic study of a human brain and glioblastoma multiforme after the in vivo uptake of tritiated thymidine. Cancer 13, 636–642 (1960).
Johnson, R.E., Pomeroy, T.C.: Integrated therapy for Ewing’s sarcoma. Amer. J. Roentgenol. 114, 532–535 (1972).
Kallman, R.F.: The phenomenon of reoxygenation and its implications for fractionated radio-therapy. Radiology 105, 135–142 (1972).
Kaplan, H.S.: Radiobiology’s contribution to radiotherapy: promise or mirage? Failla Memorial Lecture. Radiat. Res. 43, 460–476 (1970).
Kaplan, H.S.: Enzymatic repair of radiation-induced strand breakage in cellular DNA and its chemical inhibition. Radiology 105, 121–126 (1972).
Kaplan, H.S., Earle, J.D., Howsden, F.L.: The role of purine and pyrimidine bases and their analogues in radiation sensitivity. J. cell. comp. Physiol. 64, 69–90 (1964).
Kaplan, H.S., Smith, K.C., Tomlin, P.A.: Radiosensitization of E. coli by purine and pyrimidine analogues incorporated in deoxyribonucleic acid. Nature (Lond.) 190, 794–803 (1961).
Kaplan, H.S., Smith, K. C., Tomlin, P. A.: Effects of halogenated pyrimidines on the radiosensitivity of E. coli. Radiat. Res. 16, 98–107 (1962).
Kapp, D.S., Smith, K.C.: Lack of in vitro repair of x-ray induced chain breaks in DNA by the polynucleotide-joining enzymes. Int. J. Radiat. Biol. 14, 567–571 (1969).
Kapp, D.S., Smith, K.C.: The chemical inhibition of the repair of single-strand breaks in DNA: post-irradiation sensitization to x-rays. Int. J. Radiat. Biol. 19, 255–262 (1971).
Kramer, S.: Use of methotrexate and radiation therapy for advanced cancer of the head and neck. Frontiers of Radiation Therapy and Oncology, Vol. 4. Basel-New York: Karger; San Francisco: Vaeth 1969.
Krant, M.J., Chalmers, T.C., Dederick, M.M., Hall, T.C., Levele, M.B., Muench, H., Shnider, B.L., Gold, G.L., Hunter, C., Bersak, S.R., Owens, A.H., DeLeon, N., Dickson, R. J., Bundley, C., Brace, K.C., Frei, E., Gehan, E., Savin, L.: Comparative trial of chemotherapy and radiotherapy in patients with non-resectable cancer of the lung. Amer. J. Med. 35, 363–370 (1963).
Kriss, J.P., Revesz, L.: The distribution and fate of bromodeoxyuridine and bromodeoxy-cytidine in the mouse and rat. Cancer Res. 22, 254–263 (1962).
Kriss, J.P., Shaw, R.K., Lovinger, R., Edmonds, N.: Measurement of the in vivo degradation of carbon-14-labeled thymidine and its halogenated analogues in man by continuous monitoring of expired carbon-14-carbon dioxide. Nature (Lond.) 202, 1021–1030 (1964).
Lerner, H.J., Beckloff, G.L., Godwin, M.C.: Hydroxyurea (NSC-32065) intermittent therapy in malignant diseases. Cancer Chemother. Rep. 53, 385–395 (1969 a).
Lerner, H.J., Beckloff, G.L., Godwin, M.C.: Concomitant hydroxyurea and radiotherapy in the management of 60 patients with head and neck cancer. Amer. Surgeon 35, 525–534 (1969b).
Lerner, H.J., Beckloff, R.L., Godwin, M.C.: Treatment of astrocytoma with hydroxyurea and irradiation: report of six patients with 18-month follow-up. Amer. Surgeon 36, 401–402 (1970).
Lett, C.J., Feldschreiber, P., Lett, J.T.: Repair of x-ray damage to the deoxyribonucleic acid in Micrococcus radiodurans. Nature (Lond.) 209, 59–62 (1966).
Lett, J.T., Parkins, G., Alexander, P., Ormerod, M.G.: Mechanisms of sensitization to x-rays of mammalian cells by 5-bromodeoxyuridine. Nature (Lond.) 203, 593–602 (1964).
Lipshutz, H., Lerner, H.: Three year observation of combined treatment for far advanced cancer of the head and neck. Amer. J. Surg. 118, 698–700 (1969).
Madoc-Jones, H., Mauro, F.: Age responses to x-rays, vinca alkaloids, and hydroxyurea of murine lymphoma cells synchronized in vivo. J. nat. Cancer Inst. 45, 1131–1143 (1970).
Maier, J. G., Aarestad, N. O.: Concepts in the treatment of Wilms’ tumor. Frontiers of Radiation Therapy and Oncology, Vol. 4. Basel-New York: Karger; San Francisco: Vaeth 1969.
Marin, G., Levis, A. G.: X-radiation and nitrogen mustard interaction in mammalian cells grown in vitro. Radiat. Res. 23, 192–201 (1964).
Maruyama, Y., Silini, G., Kaplan, H.S.: Studies of the LSA ascites lymphoma of C-57B1 mice. II. Radiosensitization in vivo with 5-bromodeoxycytidine and combined 5-fluoro-deoxyuridine and 5-bromodeoxycytidine. Int. J. Radiat. Biol. 7, 453–462 (1963).
Mendolsohn, M.L.: Autoradiographic analysis of cell proliferation in spontaneous breast cancer of the C3H mouse. III. The growth fraction. J. nat. Cancer Inst. 28, 1015–1029 (1962).
Milne, E.N., Noonan, C.D., Margulis, A.R., Stoughton, J.A.: Vascular supply of pulmonary metastases. Experimental study in rats. Invest. Radiol. 4, 215–229 (1969).
Moertel, C.G., Childs, D.S., Jr., Reitemeier, R. J., Colby, M.Y., Jr., Holbrook, M.A.: Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 25, 865–867 (1969).
Mohler, W.C., Elkind, M.M.: Radiation response of mammalian cells grown in culture. III. Modification of x-ray survival of Chinese hamster cells by 5-bromodeoxyuridine. Exp. Cell Res. 30, 481–491 (1963).
Nelsen, T.S., Eigenbrot, E.H., Bagshaw, M.A.: Low-flow fail-safe intra-arterial infusion. Arch. Surg. 87, 124–128 (1963).
Painter, R.B., Cleaver, J. R.: Repair replication in Hela cells after large doses of x-irradiation. Nature (Lond.) 216, 369–378 (1967).
Papac, R.J., Jacobs, E.M., Faye, L.V., Jr., Donahue, D.M.: Systemic therapy with amethopterin in squamous carcinoma of the head and neck. Cancer Chemother. Rep. 32, 47–53 (1963).
Paterson, E.: Evaluation of chemotherapeutic compounds in the reticuloses. Brit. J. Cancer 12, 332–342 (1958).
Paterson, E.: Evaluation of chemotherapeutic compounds in the reticuloses. Acta un. int. cancr. 16, 518–523 (1960).
Phillips, R.A., Tolmach, L. J.: Repair of potentially lethal damage in x-irradiated Hela cells. Radiol. Res. 20, 413–432 (1966).
Prout, G.R., Jr., Slack, N.H., Bross, I.D.J.: Irradiation and 5-fluorouracil as adjuvants in the management of invasive bladder carcinoma. A cooperative group report after 4 years. J. Urol. 104, 116–129 (1970).
Prttsoff, W.H., Cramer, J.W., Chtt, M.Y., Welch, A.D.: 5-Bromo-2′-deoxycytidine (BCdR). I. Studies on metabolism in vitro and in mice. Biochem. Pharmacol. 8, 324–326 (1961).
Puck, T.T., Marcus, P.I.: Action of x-rays on mammalian cells. J. exp. Med. 103, 653–666 (1956).
Ragni, G., Szybalski, W.: Molecular radiobiology of human cell lines. II. Effects of thymidine replacement by halogenated analogues on cell inactivation by decay of incorporated radio-phosphorus. J. molec. Biol. 4, 338–346 (1962).
Rasmussen, R.E., Painter, R.B.: Radiation-stimulated DNA synthesis in cultured mammalian cells. J. cell. Biol. 29, 11–19 (1966).
Regaud, C.: Influence de la durée d’irradiation sur les effects déterminés dans le testicule par le radium. C. R. Soc. Biol. (Paris) 86, 787–790 (1922).
Reich, E.: Actinomycin: correlation of structure and function of its complexes with purines and DNA. Science 143, 684–693 (1964).
Sano, K., Hoshino, T., Nagai, M.: Studies on incorporation of a radiosensitizer 5-bromo-2′-deoxyuridine into brain tumor cells and their clinical application. Neurol. Radiol. (Tokyo) 7, 4–11(1966).
Sears, M.E.: Erythema in areas of previous irradiation in patients treated with hydroxyurea (NSC-32065). Cancer Chemother. Rep. 40, 31–32 (1964).
Sinclair, W.K.: Hydroxyurea: differential lethal effects on cultured mammalian cells during the cell cycle. Science 150, 1729–1731 (1965).
Skipper, H.E.: Perspectives in cancer chemotherapy: therapeutic design. Cancer Res. 24, 1295–1302 (1964).
Skipper, H.E., Hutchison, D. J., Schabel, F.M., Jr., Schmidt, L.H., Boldin, A., Brockman, R.W., Venditti, J.M., Wodinsky, L.: A quick reference chart on cross resistance between anticancer agents. Cancer Chemother. Rep. 56, 493–498 (1972).
Suit, H.D.: Consideration of fractionation schedules for radiation dose. Radiology 105, 151–156 (1972).
Suit, H.D., Hewitt, R., Urano, M., Muruyama, Y.: Effects of radiosensitizing agents in radiation therapy of mouse mammary carcinoma. Radiology 94, 180–195 (1970).
Suit, H.D., Lindberg, R., Fletcher, G.H.: Prognostic significance of extent of tumor regression at completion of radiation therapy. Radiology 84, 1100–1107 (1965).
Suit, H.D., Urano, M., Hewitt, R.: Effect of radiation sensitizing agents in radiation therapy of a mouse mammary carcinoma. Frontiers of radiation therapy and oncology, Vol. 4. Basel-New York: Karger; San Francisco: Vaeth 1969.
Szybalski, W., Lorkiewicz, Z.: On the nature of the principle target of lethal and mutagenic radiation effects. Abhand. Deut. Akad. Wiss., Berlin, K l, Med. 1, 61–71 (1962).
Tanaka, Y., Takahasi, M.: Clinical studies of intra-arterial infusion of 5-bromodeoxyuridine plus 5-fluorouracil and radiation. Radiation Protection and Sensitization. London: Taylor and Francis 1970.
Terasima, T., Tolmach, L.J.: Variations in several responses of Hela cells to x-irradiation during the division cycle. Biophys. J. 3, 11–33 (1963).
Vaeth, J.M.: Frontiers of Radiation Therapy and Oncology, Vol. 4. Basel-New York: Karger; San Francisco: Vaeth 1969.
Vermund, H., Hodgett, J., Ansfield, F.J.: Effects of combined roentgen irradiation and chemotherapy on transplanted tumors in mice. Amer. J. Roentgenol. 85, 559–571 (1961).
Vietti, T., Eggerding, F., Valeriote, F.: Combined effect of X-radiation and 5-fluorouracil on survival of transplanted leukemic cells. J. nat. Cancer Inst. 47, 865–870 (1971).
Von Essen, C.F., Kugerman, M.M., Calabresi, P.: Radiation and 5-fluorouracil: a controlled clinical study. Radiology 81, 1018–1030 (1963).
Whitmore, G.F., Gulyas, S., Botond, J.: Radiation sensitivity throughout the cell cycle in its relationship to recovery. Cellular Radiation Biology. Baltimore: Williams and Wilkins 1965.
Whitmore, G.F., Till, J.E.: Quantitation of cellular radiobiological response. Ann. Rev. nucl. Med. 14, 347–374 (1964).
Wolff, J.A., Krivit, W., Newton, W.A., Jr., D’Angio, G.J.: Single versus multiple dose dactinomycin therapy of Wilms’ tumor. N. Engl. J. Med. 279, 290–322 (1968).
Woodman, R.J.: Localized incorporation of iododeoxyuridine from polycation-complexed iododeoxycytidylic acid into DNA of several murine and hamster tumors. Cancer Res. 28, 2007–2016 (1968).
Yabbro, J.W.: Further studies on the mechanism of action of hydroxyurea. Cancer Res. 28, 1082–1087 (1968).
Zimbrick, J.D., Ward, J.F., Myers, L.S., Jr.: Studies on the chemical basis of cellular radio-sensitization in DNA. I. Pulse- and steady-state radiolysis of 5-bromouracil and thymine. Int. J. Radiat. Biol. 16, 505–523 (1969a).
Zimbrick, J.D., Ward, J.F., Myers, L.S., Jr.: Studies on the chemical basis of cellular radio-sensitization in DNA. II. Pulse- and steady-state radiolysis of bromouracil-substituted and unsubstituted DNA. Int. J. Radiat. Biol. 16, 525–534 (1969b).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1974 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Doggett, R.L.S., Bagshaw, M.A. (1974). Clinical and Laboratory Investigation of Combination Radiation and Chemical Therapy. In: Sartorelli, A.C., Johns, D.G. (eds) Antineoplastic and Immunosuppressive Agents Part I. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 38 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65678-1_25
Download citation
DOI: https://doi.org/10.1007/978-3-642-65678-1_25
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65680-4
Online ISBN: 978-3-642-65678-1
eBook Packages: Springer Book Archive